T he studies published in this issue of the JDR Clinical & Translational
Research address topics of importance in clinical care and care provision. These reports cover a range of matters of significance to patients, providers, and policy-makers.
Some work environments, including dental offices, contain health hazards for dentists and staff; the noise from drills, suction devices and ultrasonic cleaners can substantially harm hearing. Spomer et al. (2017) asked dental clinicians to assess 4 different types of protective hearing devices and to indicate the most important factors in their evaluations. Investigations like this are necessary to provide a scientific basis on which to develop education and protocols that can reduce noise hazards and risk of hearing loss in our dental workforce. While this report does not provide direct evidence on the efficacy of protective hearing devices in preventing long-term hearing loss (long-term randomized controlled trials are needed), it does remind us that we should not ignore the occupational hazards inherent in dental practice. We teach our dental students about the importance of good posture to reduce back/neck pain, and we equip students with masks and gloves to protect themselves, as well as their patients, from infection and spread of micro-organisms. The question now is: Should we teach dental students to use protective hearing devices that will reduce future hearing loss, at least until the technology is improved enough to reduce the noise that causes hearing loss?
As dentists increase their use of composite restorations, it is crucial that we provide scientific evidence on any potential health risks that these materials may pose to patients. In this report by MacAulay et al. (2017) , the biostability of two commonly used commercial composites was tested in a cohort of 58 participants requiring Class III and/or Class V nonocclusal restorations. Along with evidence from other in vivo studies, their results can be used by clinicians to reassure patients that restoration of their nonoccluding surfaces with these composites should not expose them to potentially harmful degradation products.
While some (younger) readers might not relate to the basis of the Ishida et al. (2017) hypothesis, I certainly do.
As a dental student in the USA in the mid 70's, I was taught that neurotic patients, in general, would not respond as well to their removable prosthodontic treatments as non-neurotic patients. This was long before we began to ask patients themselves about their satisfaction with these treatments; this was a time when we thought that we were the expert judges on the quality of a prosthesis. Thus, if a patient did not manage to cope well with our prosthetic "solution", we could place the blame on that patient's neuroticism. What the Ishida et al. (2017) report suggests is that, although patients with higher levels of neuroticism may experience poorer oral health-related quality of life (OHRQoL) with a flawed prosthesis, their OHRQoL significantly improves following receipt of an upgraded device. Whereas attitudes may have changed since the time I was in dental school, it is probable that there are still places where patients who cannot cope with their removable prosthetic devices are dismissed as "neurotic." Thus, this report is a reminder that neuroticism does not necessarily result in poor prosthetic treatment outcomes. The increased use of patient-reported outcome measures in prosthodontic research is slowly The importance of patient feedback, as well as interaction amongst patients, is exemplified by a recent op-ed in the New York Times, in which the author responded to Senator John McCain's diagnosis of glioblastoma. The author, Jessica Morris, was diagnosed with the same tumor 18 months before, and her message is quite moving. However, I was also struck by her comments on what she terms as "patient power," as well as the fact that she is working with app developers on a tool that patients can use to share their treatment strategies. She writes: "The element often lost amid the high-tech therapy is patient power.
It is patients' actions, knowledge and strength that, in tandem with worldclass scientists and supportive public servants, will find a way through. By pooling patients' experiences through tools like the smartphone app I'm helping to develop, we can improve the medical advice that other people with glioblastoma are getting, and help to fast-track the recruitment of people to clinical trials."
Although her app may not be exactly what we might need for oral health conditions, the point that Ms. Morris has made with her example applies to patients of all kinds. Patient input and participation in oral health research and policy should be encouraged and supported by us all, and our uptake of participatory research strategies can further help to start the process of "patient power" in oral health.
